.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Federal Trade Commission
Novartis
Boehringer Ingelheim
Mallinckrodt
US Department of Justice
Johnson and Johnson
AstraZeneca
Cerilliant

Generated: February 18, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: empagliflozin; metformin hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.N0597-0280-36
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.N0597-0280-90
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.N0597-0280-73
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.N0597-0290-20
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.N0597-0290-74
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.N0597-0290-59
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.N0597-0295-78
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.N0597-0295-88
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.N0597-0295-61
Boehringer IngelheimSYNJARDY XRempagliflozin; metformin hydrochlorideTABLET, EXTENDED RELEASE;ORAL208658NDABoehringer Ingelheim Pharmaceuticals, Inc.N0597-0300-93
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Harvard Business School
Daiichi Sankyo
McKinsey
Express Scripts
Julphar
Fish and Richardson
Novartis
Federal Trade Commission
Cipla

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot